Clinical Trial Update: R2-CHOP in Untreated DEL-DLBCL：An Open-lable，Multicenter，Phase II Study [Phase 2]

View source ↗

Summary

Phase II open-label multicenter trial of R2-CHOP in untreated DEL-DLBCL.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• R2-CHOP

Snippet

Sponsor: Sun Yat-sen University | Conditions: DLBCL | Phase 2 | Status: UNKNOWN